Perfluorohexyloctane Patent Expiration

Perfluorohexyloctane is Used for managing dry eye disease symptoms. It was first introduced by Bausch And Lomb Inc in its drug Miebo on May 18, 2023.


Perfluorohexyloctane Patents

Given below is the list of patents protecting Perfluorohexyloctane, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Miebo US10507132 Topical administration method Jun 21, 2037 Bausch And Lomb Inc
Miebo US11357738 Semifluorinated compounds and their compositions Sep 29, 2036 Bausch And Lomb Inc
Miebo US10058615 Semifluorinated alkane compositions Sep 12, 2033 Bausch And Lomb Inc
Miebo US10369117 Compositions comprising mixtures of semifluorinated alkanes Sep 12, 2033 Bausch And Lomb Inc
Miebo US10449164 Methods of treating ocular disorders using semifluorinated alkanes Sep 12, 2033 Bausch And Lomb Inc
Miebo US10576154 Semifluorinated alkane compositions Sep 12, 2033 Bausch And Lomb Inc



Perfluorohexyloctane's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List